Jennifer L. Taubert - Nov 22, 2022 Form 4 Insider Report for JOHNSON & JOHNSON (JNJ)

Role
EVP, WW Chair, Pharmaceuticals
Signature
Raavi K. Deol, as attorney-in-fact for Jennifer L. Taubert
Stock symbol
JNJ
Transactions as of
Nov 22, 2022
Transactions value $
-$8,018,407
Form type
4
Date filed
11/23/2022, 03:44 PM
Previous filing
Oct 7, 2022
Next filing
Jan 4, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction JNJ Common Stock Options Exercise $5.58M +76.9K +60.83% $72.54 203K Nov 22, 2022 Direct
transaction JNJ Common Stock Sale -$13.6M -76.9K -37.82% $176.78 126K Nov 22, 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction JNJ Employee Stock Options (Right to Buy) Options Exercise $0 -76.9K -100% $0.00* 0 Nov 22, 2022 Common Stock 76.9K $72.54 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This transaction was executed in multiple trades at prices ranging from $176.525 to $177.190. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide, upon request, to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.